Brief: Cocrystal Pharma reports Q2 results
15/08/2022 13:14
Aug 15 (Reuters) - Cocrystal Pharma Inc COCP.O :
* COCRYSTAL PHARMA REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS
AND PROVIDES UPDATES ON ITS ANTIVIRAL DEVELOPMENT PROGRAMS
* COCRYSTAL PHARMA INC - QTRLY LOSS PER SHARE $0.25
* COCRYSTAL PHARMA INC - QTRLY NET LOSS $24.4 MILLION VERSUS
$3.8
MILLION
* COCRYSTAL PHARMA INC- BELIEVES CASH BALANCE IS SUFFICIENT
TO
FUND PLANNED OPERATIONS INTO 2024
Source text for Eikon: ID:nGNX3R7FWw
Further company coverage: COCP.O
Recent news on Cocrystal Pharma
See all newsBrief: Cocrystal Pharma Announces Last Subject Dosed In Phase 1b Human Challenge Study Evaluating CDI-988 For Norovirus Prevention And Treatment
Cocrystal Pharma Inc reports results for the quarter ended June 30 - Earnings Summary
Cocrystal Pharma Inc expected to post a loss of 16 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Medtronic, Macy's, USA Rare Earth
U.S. STOCKS ON THE MOVE-USA Rare Earth, MiniMed, Rent the Runway